BD and Wellstar Health System have formed a partnership to enhance the safety and efficiency of medication delivery throughout Wellstar’s hospitals and care facilities.

Medtronic has received the CE mark for its VitalFlow Transport Frame AG, which functions as an accessory to the VitalFlow ECMO system.

Olympus has signed an exclusive global agreement to distribute EndoRobotics’ robot-assisted technologies as part of its EndoTherapy portfolio.

J&J hopes Ottava will boost its standing in the growing surgical robotics market, which is currently dominated by Intuitive Surgical.

Insulet has commenced patient enrolment in its pivotal EVOLVE study, evaluating a fully closed-loop AID system for adults with T2D.

The funds will advance Axoft’s existing clinical trial programmes and progress US regulatory activities for its implantable brain-computer interface.

InspireMD has issued a voluntary recall of its CGuard Prime 135cm carotid stent delivery system in the US, following consultation with the US FDA.

TaeWoong Medical has secured the US FDA clearance to commercialise the Niti-S Spaxus Stent, expanding its range of EUS-guided therapeutic solutions.

MintNeuro has signed a partnership with Motif Neurotech to advance the development of miniature BCI therapy for mental health conditions.

VVeno Medical has received the IDE approval from the US FDA for a pivotal study involving a non-surgical replacement venous valve.

The FDA has awarded a breakthrough device designation for Capitan Orthopedics' SupraSpacer implant for patients with irreparable rotator cuff tears.

Dexcom is maintaining its prior FY26 outlook in view of the current geopolitical realities such as higher oil prices due to Iran’s closure of the Strait of Hormuz in response to the US-Israel’s war ...